COVID-19 vaccine candidate was found to be safe and well-tolerated in an early-stage human trial, Zydus Cadila said on Wednesday.
Now the company will start a mid-stage trial of the vaccine candidate, ZyCoV-D, in over 1,000 healthy adult volunteers. The trial will start from Thursday to test its effectiveness, it said in a regulatory filing.
Zydus Cadila plans to complete late-stage trials for ZyCoV-D till February or March. The company can produce up to 100 million doses a year initially, the company’s chairman told Reuters last month.
Zydus is also among the several Indian company that have licensing agreements with US-based Gilead Sciences to produce remdesivir. Remdesvir is the antiviral that has been approved in the country as an emergency treatment to fight the coronavirus outbreak.
In view of Covid-19 protocol violations in departmental stores in various places, state police have issued a set of detailed guidelines to be followed by hypermarkets, including margin free markets for the safe functioning during the Covid emergency.
State Command Control Room, Andhra Pradesh- 10,328 new Covid-19 cases, 72 deaths & 8516 recoveries reported in the last 24 hours in Andhra Pradesh. Total cases rise to 1,96,789 including 1,12,870 recoveries and 1,753 deaths. Number of active cases stands at 82,166.
Madhya Pradesh Home Minister Narottam Mishra – It has been decided that lockdown will be in place on Sundays only in Bhopal & some other districts. Hotels and restaurants can now function till 10 pm. The curfew will remain in place between 10 pm and 5 am.
